Fenretinide as an anti-angiogenic agent in neuroblastoma

Domenico Ribatti; Lizzia Raffaghello; Danilo Marimpietri; Emilio Cosimo; P. Giuseppe Montaldo; Beatrice Nico; Angelo Vacca; Mirco Ponzoni

doi:10.1016/S0304-3835(03)00105-8

Fenretinide as an anti-angiogenic agent in neuroblastoma

Domenico Ribatti, Lizzia Raffaghello, Danilo Marimpietri, Emilio Cosimo, P. Giuseppe Montaldo, Beatrice Nico, Angelo Vacca, Mirco Ponzoni

Research output: Contribution to journal › Article › peer-review

Abstract

Angiogenesis is a critical event in the progression of human neuroblastoma. This mini-review summarizes our literature and experimental data concerning the use of anti-angiogenic molecules, such as TNP-470 and fenretinide, in neuroblastoma treatment.

Original language	English
Pages (from-to)	181-184
Number of pages	4
Journal	Cancer Letters
Volume	197
Issue number	1-2
DOIs	https://doi.org/10.1016/S0304-3835(03)00105-8
Publication status	Published - Jul 18 2003

Keywords

Angiogenesis
Anti-angiogenesis
Endothelial cells
Fenretinide
HPR
Neuroblastoma
Progression
Therapy
TNP-470
Vascular network

ASJC Scopus subject areas

Cancer Research
Molecular Biology
Oncology

Access to Document

10.1016/S0304-3835(03)00105-8

Cite this

@article{355efb77a2fc4276b1b6dd143a32f069,

title = "Fenretinide as an anti-angiogenic agent in neuroblastoma",

abstract = "Angiogenesis is a critical event in the progression of human neuroblastoma. This mini-review summarizes our literature and experimental data concerning the use of anti-angiogenic molecules, such as TNP-470 and fenretinide, in neuroblastoma treatment.",

keywords = "Angiogenesis, Anti-angiogenesis, Endothelial cells, Fenretinide, HPR, Neuroblastoma, Progression, Therapy, TNP-470, Vascular network",

author = "Domenico Ribatti and Lizzia Raffaghello and Danilo Marimpietri and Emilio Cosimo and Montaldo, {P. Giuseppe} and Beatrice Nico and Angelo Vacca and Mirco Ponzoni",

year = "2003",

month = jul,

day = "18",

doi = "10.1016/S0304-3835(03)00105-8",

language = "English",

volume = "197",

pages = "181--184",

journal = "Cancer Letters",

issn = "0304-3835",

publisher = "Elsevier Ireland Ltd",

number = "1-2",

}

TY - JOUR

T1 - Fenretinide as an anti-angiogenic agent in neuroblastoma

AU - Ribatti, Domenico

AU - Raffaghello, Lizzia

AU - Marimpietri, Danilo

AU - Cosimo, Emilio

AU - Montaldo, P. Giuseppe

AU - Nico, Beatrice

AU - Vacca, Angelo

AU - Ponzoni, Mirco

PY - 2003/7/18

Y1 - 2003/7/18

N2 - Angiogenesis is a critical event in the progression of human neuroblastoma. This mini-review summarizes our literature and experimental data concerning the use of anti-angiogenic molecules, such as TNP-470 and fenretinide, in neuroblastoma treatment.

AB - Angiogenesis is a critical event in the progression of human neuroblastoma. This mini-review summarizes our literature and experimental data concerning the use of anti-angiogenic molecules, such as TNP-470 and fenretinide, in neuroblastoma treatment.

KW - Angiogenesis

KW - Anti-angiogenesis

KW - Endothelial cells

KW - Fenretinide

KW - HPR

KW - Neuroblastoma

KW - Progression

KW - Therapy

KW - TNP-470

KW - Vascular network

UR - http://www.scopus.com/inward/record.url?scp=0038782392&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038782392&partnerID=8YFLogxK

U2 - 10.1016/S0304-3835(03)00105-8

DO - 10.1016/S0304-3835(03)00105-8

M3 - Article

C2 - 12880979

AN - SCOPUS:0038782392

VL - 197

SP - 181

EP - 184

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 1-2

ER -

Fenretinide as an anti-angiogenic agent in neuroblastoma

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this